Healthcare -
Biotechnology - NYSE - US
$ 1.75
-4.37 %
$ 34.1 M
Market Cap
-0.41
P/E
ANVS - NET CHANGE IN CASH
Net Change in Cash ANVS - Annovis Bio, Inc.
-22.6 M
LAST VALUE
-26.55%
2 YEAR CAGR
-135.52%
5 YEAR CAGR
0.00%
10 YEAR CAGR